Early enamel mineral loss can be reversed; a formed cavity does not simply grow back. Neither statement means that a missing adult tooth can regrow. NIDCR describes early decay as a process in which minerals can be lost and replaced, while an established cavity represents permanent damage that requires repair. 1
The word “regrow” is doing too much work when it is used for all three situations. Separating them gives a more useful answer than an unqualified yes or no.
The condition of the tooth changes the answer
| Situation | What is being discussed | What “regrowth” would misleadingly imply |
|---|---|---|
| Early mineral loss in enamel | Remineralization of an existing surface | Creation of a new whole tooth |
| An established cavity | Repair of damaged tooth structure | That lost structure necessarily returns on its own |
| A tooth absent from the mouth | Replacement or investigational whole-tooth development | That an enamel-care product replaces the missing organ |
The first two distinctions come from NIDCR's explanation of tooth decay. The third belongs to a separate research and replacement question. 1 2
Remineralization is a repair process, not a new generation of teeth
NIDCR explains that minerals supplied through saliva and fluoride can help reverse early mineral loss. The process concerns an existing tooth surface before decay has progressed to a cavity. 1
That makes the timing and type of damage central. A claim about preventing progression of early decay should not be rewritten as a promise to reconstruct a missing tooth. The words sound related, but the proposed outcomes are on different scales.
This article does not diagnose whether an individual mark is early demineralization or an established cavity. Its purpose is to explain why an accurate statement about one cannot automatically answer a question about the other.
Why the TRG035 research is different
TRG035 is a drug-development program initially directed at congenital tooth agenesis, not a remineralizing toothpaste. The developer's August 2026 notice concerns an exploratory Phase IIa trial pathway. 3
A product page mentioning regeneration does not establish a relationship to that program. To describe two products as the same approach, evidence would need to connect their actual intervention and intended use—not merely their marketing vocabulary.
The full tooth-regrowth guide keeps the drug program, early surface repair and replacement dentistry in separate categories.
What about implants?
The FDA describes a dental implant as a surgically placed system that supports an artificial restoration. It replaces a function of the absent tooth rather than making a new natural tooth develop. 2
That does not make the distinction a value judgment. An artificial replacement can be useful; a biological effect can remain experimental. The correct comparison concerns suitability, function, risks and evidence, not whether one label sounds more natural.
How to interpret a product's promise
The useful question is what the promised outcome actually is. “Supports remineralization” is a different proposition from “repairs a cavity,” and both differ from “grows a new adult tooth.” Evidence should match the claim being sold.
For example, a hypothetical study measuring mineral change on enamel would not establish a whole-tooth-regrowth success rate. That conclusion follows from the difference in endpoints, even before considering the quality of the study.
There is no need to dismiss legitimate early-decay prevention to reject an unsupported broader claim. The accurate answer is narrower and more useful: some early surface mineral loss can be reversed; an existing cavity and a completely missing tooth are not the same problem.
For the separate replacement question, continue to tooth regrowth versus dental implants. For the investigational drug, use the TRG035 status report.